Management of Elevated Systolic Velocities in Renal Transplant Patients

Diagnostic Approach and Management

• The American Heart Association recommends targeting a blood pressure of <130/80 mmHg in adult kidney transplant recipients, with calcium channel blockers (CCBs) as preferred first-line agents due to improved GFR and kidney survival 2, 3
• Resistant hypertension despite multiple antihypertensive medications is a consideration for Transplant Renal Artery Stenosis (TRAS) 1
• The American College of Cardiology suggests that hypertension is common after kidney transplantation, with a prevalence of over 65%, and contributes to cardiovascular morbidity and mortality 1
• Calcineurin inhibitors are major contributors to post-transplant hypertension, and CCBs are preferred due to better compatibility with these medications 1, 2
• Initially after transplantation, less stringent BP targets (<160/90 mmHg) may be appropriate to maintain adequate organ perfusion and avoid graft thrombosis 2
• When using ACE inhibitors or ARBs, monitor serum creatinine and potassium closely, as a significant increase in creatinine should raise suspicion for renal artery stenosis 1